Human Gene NF2 (uc003age.4)
  Description: Homo sapiens neurofibromin 2 (merlin) (NF2), transcript variant 1, mRNA.
RefSeq Summary (NM_000268): This gene encodes a protein that is similar to some members of the ERM (ezrin, radixin, moesin) family of proteins that are thought to link cytoskeletal components with proteins in the cell membrane. This gene product has been shown to interact with cell-surface proteins, proteins involved in cytoskeletal dynamics and proteins involved in regulating ion transport. This gene is expressed at high levels during embryonic development; in adults, significant expression is found in Schwann cells, meningeal cells, lens and nerve. Mutations in this gene are associated with neurofibromatosis type II which is characterized by nervous system and skin tumors and ocular abnormalities. Two predominant isoforms and a number of minor isoforms are produced by alternatively spliced transcripts. [provided by RefSeq, Jul 2008].
Transcript (Including UTRs)
   Position: hg19 chr22:29,999,545-30,094,589 Size: 95,045 Total Exon Count: 16 Strand: +
Coding Region
   Position: hg19 chr22:29,999,988-30,090,791 Size: 90,804 Coding Exon Count: 16 

Page IndexSequence and LinksUniProtKB CommentsPrimersGenetic AssociationsMalaCards
CTDGene AllelesRNA-Seq ExpressionMicroarray ExpressionRNA StructureProtein Structure
Other SpeciesGO AnnotationsmRNA DescriptionsPathwaysOther NamesGeneReviews
Model InformationMethods
Data last updated at UCSC: 2013-06-14

-  Sequence and Links to Tools and Databases
 
Genomic Sequence (chr22:29,999,545-30,094,589)mRNA (may differ from genome)Protein (595 aa)
Gene SorterGenome BrowserOther Species FASTAVisiGeneGene interactionsTable Schema
AlphaFoldBioGPSEnsemblEntrez GeneExonPrimerGeneCards
GeneNetworkH-INVHGNCHPRDLynxMalacards
MGIneXtProtOMIMPubMedReactomeTreefam
UniProtKBWikipediaBioGrid CRISPR DB

-  Comments and Description Text from UniProtKB
  ID: MERL_HUMAN
DESCRIPTION: RecName: Full=Merlin; AltName: Full=Moesin-ezrin-radixin-like protein; AltName: Full=Neurofibromin-2; AltName: Full=Schwannomerlin; AltName: Full=Schwannomin;
FUNCTION: Probable regulator of the Hippo/SWH (Sav/Wts/Hpo) signaling pathway, a signaling pathway that plays a pivotal role in tumor suppression by restricting proliferation and promoting apoptosis. Along with WWC1 can synergistically induce the phosphorylation of LATS1 and LATS2 and can probably function in the regulation of the Hippo/SWH (Sav/Wts/Hpo) signaling pathway. May act as a membrane stabilizing protein. May inhibit PI3 kinase by binding to AGAP2 and impairing its stimulating activity. Suppresses cell proliferation and tumorigenesis by inhibiting the CUL4A-RBX1-DDB1-VprBP/DCAF1 E3 ubiquitin-protein ligase complex.
SUBUNIT: Interacts with SLC9A3R1, HGS and AGAP2. Interacts with LAYN (By similarity). Interacts with SGSM3. Interacts (via FERM domain) with MPP1. Interacts with WWC1. Interacts with the CUL4A- RBX1-DDB1-VprBP/DCAF1 E3 ubiquitin-protein ligase complex. The unphosphorylated form interacts (via FERM domain) with VPRBP/DCAF1.
INTERACTION: Q4VCS5:AMOT; NbExp=7; IntAct=EBI-1014472, EBI-2511319; Q4VCS5-1:AMOT; NbExp=2; IntAct=EBI-1014472, EBI-3903812; Q4VCS5-2:AMOT; NbExp=6; IntAct=EBI-1014472, EBI-3891843; Q9BZE4:GTPBP4; NbExp=9; IntAct=EBI-1014472, EBI-1056249; Q8NI35:INADL; NbExp=2; IntAct=EBI-1014472, EBI-724390; Q16584:MAP3K11; NbExp=4; IntAct=EBI-1014472, EBI-49961; Q9H204:MED28; NbExp=4; IntAct=EBI-1014472, EBI-514199; Q10728:Ppp1r12a (xeno); NbExp=2; IntAct=EBI-1014472, EBI-918263; Q3TI53:Schip1 (xeno); NbExp=2; IntAct=EBI-1014472, EBI-1397475; O14745:SLC9A3R1; NbExp=4; IntAct=EBI-1014500, EBI-349787;
SUBCELLULAR LOCATION: Isoform 1: Cell projection, filopodium membrane; Peripheral membrane protein; Cytoplasmic side. Cell projection, ruffle membrane; Peripheral membrane protein; Cytoplasmic side. Nucleus. Note=In a fibroblastic cell line, isoform 1 is found homogeneously distributed over the entire cell, with a particularly strong staining in ruffling membranes and filopodia. Colocalizes with MPP1 in non-myelin-forming Schwann cells. Binds with VPRBP in the nucleus. The intramolecular association of the FERM domain with the C-terminal tail promotes nuclear accumulation. The unphosphorylated form accumulates predominantly in the nucleus while the phosphorylated form is largely confined to the non-nuclear fractions.
SUBCELLULAR LOCATION: Isoform 7: Cytoplasm, perinuclear region. Cytoplasmic granule. Note=Observed in cytoplasmic granules concentrated in a perinuclear location. Isoform 7 is absent from ruffling membranes and filopodia.
SUBCELLULAR LOCATION: Isoform 9: Cytoplasm, perinuclear region. Cytoplasmic granule. Note=Observed in cytoplasmic granules concentrated in a perinuclear location. Isoform 9 is absent from ruffling membranes and filopodia.
SUBCELLULAR LOCATION: Isoform 10: Nucleus. Cell projection, filopodium membrane; Peripheral membrane protein; Cytoplasmic side. Cell projection, ruffle membrane; Peripheral membrane protein; Cytoplasmic side. Cytoplasm, perinuclear region. Cytoplasmic granule. Cytoplasm, cytoskeleton. Note=In a fibroblastic cell line, isoform 10 is found homogeneously distributed over the entire cell, with a particularly strong staining in ruffling membranes and filopodia.
TISSUE SPECIFICITY: Widely expressed. Isoform 1 and isoform 3 are predominant. Isoform 4, isoform 5 and isoform 6 are expressed moderately. Isoform 8 is found at low frequency. Isoform 7, isoform 9 and isoform 10 are not expressed in adult tissues, with the exception of adult retina expressing isoform 10. Isoform 9 is faintly expressed in fetal brain, heart, lung, skeletal muscle and spleen. Fetal thymus expresses isoforms 1, 7, 9 and 10 at similar levels.
PTM: Phosphorylation of Ser-518 inhibits nuclear localization by disrupting the intramolecular association of the FERM domain with the C-terminal tail.
PTM: Ubiquitinated by the CUL4A-RBX1-DDB1-DCAF1/VprBP E3 ubiquitin-protein ligase complex for ubiquitination and subsequent proteasome-dependent degradation.
DISEASE: Defects in NF2 are the cause of neurofibromatosis 2 (NF2) [MIM:101000]; also known as central neurofibromatosis. NF2 is a genetic disorder characterized by bilateral vestibular schwannomas (formerly called acoustic neuromas), schwannomas of other cranial and peripheral nerves, meningiomas, and ependymomas. It is inherited in an autosomal dominant fashion with full penetrance. Affected individuals generally develop symptoms of eighth-nerve dysfunction in early adulthood, including deafness and balance disorder. Although the tumors of NF2 are histologically benign, their anatomic location makes management difficult, and patients suffer great morbidity and mortality.
DISEASE: Defects in NF2 are a cause of schwannomatosis (SCHWA) [MIM:162091]; also known as congenital cutaneous neurilemmomatosis. Schwannomas are benign tumors of the peripheral nerve sheath that usually occur singly in otherwise normal individuals. Multiple schwannomas in the same individual suggest an underlying tumor-predisposition syndrome. The most common such syndrome is NF2. The hallmark of NF2 is the development of bilateral vestibular-nerve schwannomas; but two-thirds or more of all NF2-affected individuals develop schwannomas in other locations, and dermal schwannomas may precede vestibular tumors in NF2-affected children. There have been several reports of individuals with multiple schwannomas who do not show evidence of vestibular schwannoma. Clinical report suggests that schwannomatosis is a clinical entity distinct from other forms of neurofibromatosis.
DISEASE: Defects in NF2 may be a cause of mesothelioma malignant (MESOM) [MIM:156240]. An aggressive neoplasm of the serosal lining of the chest. It appears as broad sheets of cells, with some regions containing spindle-shaped, sarcoma-like cells and other regions showing adenomatous patterns. Pleural mesotheliomas have been linked to exposure to asbestos.
SIMILARITY: Contains 1 FERM domain.
WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and Haematology; URL="http://atlasgeneticsoncology.org/Genes/NF2117.html";
WEB RESOURCE: Name=GeneReviews; URL="http://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/gene/NF2";

-  Primer design for this transcript
 

Primer3Plus can design qPCR Primers that straddle exon-exon-junctions, which amplify only cDNA, not genomic DNA.
Click here to load the transcript sequence and exon structure into Primer3Plus

Exonprimer can design one pair of Sanger sequencing primers around every exon, located in non-genic sequence.
Click here to open Exonprimer with this transcript

To design primers for a non-coding sequence, zoom to a region of interest and select from the drop-down menu: View > In External Tools > Primer3


-  Genetic Association Studies of Complex Diseases and Disorders
  Genetic Association Database (archive): NF2
CDC HuGE Published Literature: NF2
Positive Disease Associations: Carotid atherosclerosis in HIV infection , Neurofibromatosis type 2 , neurofibromatosis2
Related Studies:
  1. Carotid atherosclerosis in HIV infection
    Shrestha ,et al. 2010, A genome-wide association study of carotid atherosclerosis in HIV-infected men, AIDS (London, England) 2009 . [PubMed 20009918]
    These results suggest that in the context of HIV infection and HAART, a functional SNP in a biologically plausible candidate gene, RYR3, is associated with increased common carotid IMT, which is a surrogate for atherosclerosis.
  2. Neurofibromatosis type 2
    Kluwe L et al. 1998, Phenotypic variability associated with 14 splice-site mutations in the NF2 gene., American journal of medical genetics. 1998 May;77(3):228-33. [PubMed 9605590]
  3. neurofibromatosis2
    Baser, M. E. et al. 2004, Genotype-phenotype correlations for nervous system tumors in neurofibromatosis 2: a population-basedstudy., American journal of human genetics. 2004 Aug;75(2):231-9. [PubMed 15190457]
    We found statistically significant genotype-phenotype correlations for intracranial meningiomas, spinal tumors, and peripheral nerve tumors. People with constitutional NF2 missense mutations, splice-site mutations, large deletions, or somatic mosaicism had significantly fewer tumors than did people with constitutional nonsense or frameshift NF2 mutations. In addition, there were significant intrafamilial correlations for intracranial meningiomas and spinal tumors, after adjustment for the type of constitutional NF2 mutation. The type of constitutional NF2 mutation is an important determinant of the number of NF2-associated intracranial meningiomas, spinal tumors, and peripheral nerve tumors.
           more ... click here to view the complete list

-  MalaCards Disease Associations
  MalaCards Gene Search: NF2
Diseases sorted by gene-association score: neurofibromatosis, type 2* (1681), schwannomatosis* (758), meningioma, familial* (540), spinal meningioma* (417), neurofibromatosis, type 1* (311), meningioma, radiation-induced* (283), acoustic neuroma (39), benign meningioma (31), neurilemmoma (31), malignant ependymoma (25), neurofibroma (24), cellular schwannoma (23), transitional meningioma (23), spinal cord ependymoma (22), neuroma (20), nervous system benign neoplasm (20), nervous system cancer (20), chronic angina (17), spinal canal and spinal cord meningioma (17), plexiform schwannoma (17), malignant peripheral nerve sheath tumor (17), plexiform neurofibroma (16), ependymoma (16), neurofibrosarcoma (16), peripheral nerve schwannoma (16), schwannoma of twelfth cranial nerve (16), hypoglossal nerve neoplasm (16), fibrous meningioma (15), mesothelioma, somatic (15), organ system benign neoplasm (13), pten hamartoma tumor syndrome (13), neurofibromatosis, familial spinal (13), monosomy 22 (12), chordoid glioma (12), spinal cancer (11), peritoneal mesothelioma (11), optic nerve sheath meningioma (11), foramen magnum meningioma (11), meningothelial meningioma (11), parasagittal meningioma (11), cerebral convexity meningioma (10), psammomatous meningioma (10), tanycytic ependymoma (9), benign mesothelioma (9), intraventricular meningioma (9), olfactory groove meningioma (8), melanotic neurilemmoma (8), anterior cranial fossa meningioma (8), malignant peritoneal mesothelioma (8), autosomal genetic disease (7), immature cataract (7), rhabdoid meningioma (7), secretory meningioma (7), lung meningioma (7), anaplastic ependymoma (7), optic nerve neoplasm (6), amyloid tumor (6), pleural cancer (6), facial nerve disease (6), small cell sarcoma (6), atypical neurofibroma (6), facial paralysis (6), benign ependymoma (5), cerebellopontine angle tumor (5), vestibular nystagmus (5), skull base meningioma (4), clear cell ependymoma (4), autosomal dominant disease (2), peripheral nervous system neoplasm (1)
* = Manually curated disease association

-  Comparative Toxicogenomics Database (CTD)
  The following chemicals interact with this gene           more ... click here to view the complete list

+  Common Gene Haplotype Alleles
  Press "+" in the title bar above to open this section.

-  RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
  Highest median expression: 13.14 RPKM in Brain - Cortex
Total median expression: 317.39 RPKM



View in GTEx track of Genome Browser    View at GTEx portal     View GTEx Body Map

+  Microarray Expression Data
  Press "+" in the title bar above to open this section.

-  mRNA Secondary Structure of 3' and 5' UTRs
 
RegionFold EnergyBasesEnergy/Base
Display As
5' UTR -250.80443-0.566 Picture PostScript Text
3' UTR -1503.423798-0.396 Picture PostScript Text

The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.

-  Protein Domain and Structure Information
  InterPro Domains: Graphical view of domain structure
IPR019749 - Band_41_domain
IPR019750 - Band_41_fam
IPR011174 - ERM
IPR011259 - ERM_C
IPR000798 - Ez/rad/moesin
IPR014352 - FERM/acyl-CoA-bd_prot_3-hlx
IPR019748 - FERM_central
IPR019747 - FERM_CS
IPR000299 - FERM_domain
IPR018979 - FERM_N
IPR018980 - FERM_PH-like_C
IPR008954 - Moesin
IPR011993 - PH_like_dom

Pfam Domains:
PF00373 - FERM central domain
PF00769 - Ezrin/radixin/moesin family
PF09379 - FERM N-terminal domain
PF09380 - FERM C-terminal PH-like domain

SCOP Domains:
47031 - Second domain of FERM
48678 - Moesin tail domain
50729 - PH domain-like
54236 - Ubiquitin-like

Protein Data Bank (PDB) 3-D Structure
MuPIT help
1H4R - X-ray MuPIT 3U8Z - X-ray MuPIT


ModBase Predicted Comparative 3D Structure on P35240
FrontTopSide
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.

-  Orthologous Genes in Other Species
  Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
MouseRatZebrafishD. melanogasterC. elegansS. cerevisiae
No orthologGenome BrowserGenome BrowserGenome BrowserNo orthologNo ortholog
Gene DetailsGene Details Gene Details  
Gene SorterGene Sorter Gene Sorter  
 RGDEnsemblFlyBase  
 Protein SequenceProtein SequenceProtein Sequence  
 AlignmentAlignmentAlignment  

-  Gene Ontology (GO) Annotations with Structured Vocabulary
  Molecular Function:
GO:0003779 actin binding
GO:0005515 protein binding
GO:0008092 cytoskeletal protein binding

Biological Process:
GO:0001707 mesoderm formation
GO:0001953 negative regulation of cell-matrix adhesion
GO:0006469 negative regulation of protein kinase activity
GO:0007398 ectoderm development
GO:0007420 brain development
GO:0008285 negative regulation of cell proliferation
GO:0014010 Schwann cell proliferation
GO:0014013 regulation of gliogenesis
GO:0021766 hippocampus development
GO:0022408 negative regulation of cell-cell adhesion
GO:0030036 actin cytoskeleton organization
GO:0030336 negative regulation of cell migration
GO:0031647 regulation of protein stability
GO:0035330 regulation of hippo signaling
GO:0042127 regulation of cell proliferation
GO:0042475 odontogenesis of dentin-containing tooth
GO:0042532 negative regulation of tyrosine phosphorylation of STAT protein
GO:0042981 regulation of apoptotic process
GO:0043409 negative regulation of MAPK cascade
GO:0045216 cell-cell junction organization
GO:0045597 positive regulation of cell differentiation
GO:0046426 negative regulation of JAK-STAT cascade
GO:0050767 regulation of neurogenesis
GO:0051496 positive regulation of stress fiber assembly
GO:0051726 regulation of cell cycle
GO:0070306 lens fiber cell differentiation
GO:0072091 regulation of stem cell proliferation
GO:1900180 regulation of protein localization to nucleus
GO:2000177 regulation of neural precursor cell proliferation

Cellular Component:
GO:0001726 ruffle
GO:0005634 nucleus
GO:0005730 nucleolus
GO:0005737 cytoplasm
GO:0005769 early endosome
GO:0005829 cytosol
GO:0005856 cytoskeleton
GO:0005886 plasma membrane
GO:0005912 adherens junction
GO:0016020 membrane
GO:0030027 lamellipodium
GO:0030175 filopodium
GO:0030864 cortical actin cytoskeleton
GO:0031527 filopodium membrane
GO:0032154 cleavage furrow
GO:0032587 ruffle membrane
GO:0042995 cell projection
GO:0043005 neuron projection
GO:0044297 cell body
GO:0045177 apical part of cell
GO:0048471 perinuclear region of cytoplasm


-  Descriptions from all associated GenBank mRNAs
  AF369657 - Homo sapiens neurofibromatosis type 2 isoform I (NF2) mRNA, complete cds, alternatively spliced.
AF369658 - Homo sapiens neurofibromatosis type 2 isoform II (NF2) mRNA, complete cds, alternatively spliced.
AK297116 - Homo sapiens cDNA FLJ61733 complete cds, highly similar to Merlin.
AF369701 - Homo sapiens IMAGE:2492737 neurofibromatosis type 2 (NF2) mRNA, complete cds.
BC020257 - Homo sapiens neurofibromin 2 (merlin), mRNA (cDNA clone MGC:32086 IMAGE:4871980), complete cds.
BC003112 - Homo sapiens neurofibromin 2 (merlin), mRNA (cDNA clone MGC:2241 IMAGE:3537045), complete cds.
L11353 - Human moesin-ezrin-radixin-like protein mRNA, complete cds.
Z22664 - H.sapiens membrane organizing protein gene.
CR456530 - Homo sapiens NF2 full length open reading frame (ORF) cDNA clone (cDNA clone C22ORF:pGEM.NF2).
AF122827 - Homo sapiens neurofibromatosis type 2 protein isoform Mer162 (NF2) mRNA, alternatively spliced, complete cds.
AF123570 - Homo sapiens neurofibromatosis type 2 protein isoform Mer150 (NF2) mRNA, alternatively spliced, complete cds.
AF122828 - Homo sapiens neurofibromatosis type 2 protein isoform Mer151 (NF2) mRNA, alternatively spliced, complete cds.
AB587384 - Synthetic construct DNA, clone: pF1KB5411, Homo sapiens NF2 gene for neurofibromin 2, without stop codon, in Flexi system.
CU013418 - Homo sapiens NF2, mRNA (cDNA clone IMAGE:100000387), complete cds, without stop codon, in Gateway system.
DQ894878 - Synthetic construct Homo sapiens clone IMAGE:100009338; FLH182387.01L; RZPDo839F09137D neurofibromin 2 (bilateral acoustic neuroma) (NF2) gene, encodes complete protein.
DQ891697 - Synthetic construct clone IMAGE:100004327; FLH182391.01X; RZPDo839F09138D neurofibromin 2 (bilateral acoustic neuroma) (NF2) gene, encodes complete protein.
CU013130 - Homo sapiens NF2, mRNA (cDNA clone IMAGE:100000483), complete cds, with stop codon, in Gateway system.
KJ891693 - Synthetic construct Homo sapiens clone ccsbBroadEn_01087 NF2 gene, encodes complete protein.
KR709843 - Synthetic construct Homo sapiens clone CCSBHm_00006747 NF2 (NF2) mRNA, encodes complete protein.
KR709844 - Synthetic construct Homo sapiens clone CCSBHm_00006750 NF2 (NF2) mRNA, encodes complete protein.
KR709845 - Synthetic construct Homo sapiens clone CCSBHm_00006778 NF2 (NF2) mRNA, encodes complete protein.
KR709846 - Synthetic construct Homo sapiens clone CCSBHm_00006794 NF2 (NF2) mRNA, encodes complete protein.
EF517524 - Homo sapiens merlin variant 14 (NF2) mRNA, complete cds, alternatively spliced.
AF369662 - Homo sapiens neurofibromatosis type 2 isoform II (NF2) mRNA, complete cds, alternatively spliced.
AF369661 - Homo sapiens neurofibromatosis type 2 isoform I (NF2) mRNA, complete cds, alternatively spliced.
AF369663 - Homo sapiens neurofibromatosis type 2 isoform delE2 (NF2) mRNA, complete cds, alternatively spliced.
AF369664 - Homo sapiens neurofibromatosis type 2 isoform delE3 (NF2) mRNA, complete cds, alternatively spliced.
AF369665 - Homo sapiens neurofibromatosis type 2 isoform delE2/3 (NF2) mRNA, complete cds, alternatively spliced.
AF369666 - Homo sapiens neurofibromatosis type 2 isoform insE1a (NF2) mRNA, complete sequence, alternatively spliced.
AF369667 - Homo sapiens neurofibromatosis type 2 isoform insE2' (NF2) mRNA, complete sequence, alternatively spliced.
AF369668 - Homo sapiens neurofibromatosis type 2 isoform ins16' (NF2) mRNA, complete sequence, alternatively spliced.
S73853 - NF2=neurofibromatosis type 2 {alternatively spliced, exon 1-2, form A4} [human, colorectal cancer, mRNA Partial Mutant, 158 nt].
AF369660 - Homo sapiens clone 2 neurofibromatosis type 2 (NF2) mRNA, partial sequence.
AF369659 - Homo sapiens clone 1 neurofibromatosis type 2 (NF2) mRNA, partial sequence.
JD213481 - Sequence 194505 from Patent EP1572962.
DQ596361 - Homo sapiens piRNA piR-34427, complete sequence.
AF369700 - Homo sapiens IMAGE:324083 neurofibromatosis type 2 (NF2) mRNA, partial cds.
S73854 - NF2=neurofibromatosis type 2 {alternatively spliced, exon 15-16, form E3} [human, colorectal cancer, mRNA Partial Mutant, 121 nt].
L28839 - Human schwannomin isoforms type IIIa and IIIb neurofibromatosis type 2 (NF2) mRNA.
S73856 - NF2=neurofibromatosis type 2 {3' region, alternatively spliced, exon 14-16, form E2} [human, colorectal cancer, mRNA Partial Mutant, 90 nt].
AK092306 - Homo sapiens cDNA FLJ34987 fis, clone OCBBF2010978.
AX747469 - Sequence 994 from Patent EP1308459.
DQ582764 - Homo sapiens piRNA piR-32876, complete sequence.
DQ571852 - Homo sapiens piRNA piR-31964, complete sequence.
DQ600961 - Homo sapiens piRNA piR-39027, complete sequence.
AK092515 - Homo sapiens cDNA FLJ35196 fis, clone PLACE6017701.
BC007279 - Homo sapiens neurofibromin 2 (merlin), mRNA (cDNA clone IMAGE:3343280).
JD335564 - Sequence 316588 from Patent EP1572962.
JD206410 - Sequence 187434 from Patent EP1572962.
BC010060 - Homo sapiens neurofibromin 2 (merlin), mRNA (cDNA clone IMAGE:3951693), with apparent retained intron.
AF369703 - Homo sapiens IMAGE:165898 neurofibromatosis type 2 (NF2) mRNA, 3' untranslated region.
JD144912 - Sequence 125936 from Patent EP1572962.
JD276849 - Sequence 257873 from Patent EP1572962.
JD099913 - Sequence 80937 from Patent EP1572962.
JD176870 - Sequence 157894 from Patent EP1572962.
JD114960 - Sequence 95984 from Patent EP1572962.
JD440664 - Sequence 421688 from Patent EP1572962.
JD454758 - Sequence 435782 from Patent EP1572962.
JD384897 - Sequence 365921 from Patent EP1572962.
JD042376 - Sequence 23400 from Patent EP1572962.
JD103510 - Sequence 84534 from Patent EP1572962.
AF113694 - Homo sapiens clone FLB5214 PRO1359 mRNA, complete cds.
JD212565 - Sequence 193589 from Patent EP1572962.
JD321926 - Sequence 302950 from Patent EP1572962.
JD072233 - Sequence 53257 from Patent EP1572962.
JD132216 - Sequence 113240 from Patent EP1572962.
JD243630 - Sequence 224654 from Patent EP1572962.
JD219133 - Sequence 200157 from Patent EP1572962.
BC071653 - Homo sapiens cDNA clone IMAGE:4366692, **** WARNING: chimeric clone ****.
JD505339 - Sequence 486363 from Patent EP1572962.
JD106884 - Sequence 87908 from Patent EP1572962.
JD382366 - Sequence 363390 from Patent EP1572962.
BC007336 - Homo sapiens neurofibromin 2 (merlin), mRNA (cDNA clone IMAGE:3631118), with apparent retained intron.
JD362465 - Sequence 343489 from Patent EP1572962.
KJ901601 - Synthetic construct Homo sapiens clone ccsbBroadEn_10995 NF2 gene, encodes complete protein.
AF369702 - Homo sapiens neurofibromatosis type 2 (NF2) mRNA, 3' untranslated region.
JD419914 - Sequence 400938 from Patent EP1572962.
JD338701 - Sequence 319725 from Patent EP1572962.
JD216975 - Sequence 197999 from Patent EP1572962.
JD393098 - Sequence 374122 from Patent EP1572962.
JD393099 - Sequence 374123 from Patent EP1572962.
JD400635 - Sequence 381659 from Patent EP1572962.
JD560450 - Sequence 541474 from Patent EP1572962.
JD275215 - Sequence 256239 from Patent EP1572962.
JD383505 - Sequence 364529 from Patent EP1572962.

-  Biochemical and Signaling Pathways
  Reactome (by CSHL, EBI, and GO)

Protein P35240 (Reactome details) participates in the following event(s):

R-HSA-5669158 NF2 binds PAK1
R-HSA-5627123 RHO GTPases activate PAKs
R-HSA-195258 RHO GTPase Effectors
R-HSA-194315 Signaling by Rho GTPases
R-HSA-162582 Signal Transduction

-  Other Names for This Gene
  Alternate Gene Symbols: MERL_HUMAN, NM_000268, NP_000259, O95683, P35240, Q8WUJ2, Q969N0, Q969Q3, Q96T30, Q96T31, Q96T32, Q96T33, Q9BTW3, Q9UNG9, Q9UNH3, Q9UNH4, SCH
UCSC ID: uc003age.4
RefSeq Accession: NM_000268
Protein: P35240 (aka MERL_HUMAN)
CCDS: CCDS13861.1, CCDS13862.1

-  GeneReviews for This Gene
  GeneReviews article(s) related to gene NF2:
nf2 (NF2-Related Schwannomatosis)

-  Gene Model Information
 
category: coding nonsense-mediated-decay: no RNA accession: NM_000268.3
exon count: 16CDS single in 3' UTR: no RNA size: 6046
ORF size: 1788CDS single in intron: no Alignment % ID: 100.00
txCdsPredict score: 3686.00frame shift in genome: no % Coverage: 99.72
has start codon: yes stop codon in genome: no # of Alignments: 1
has end codon: yes retained intron: no # AT/AC introns 0
selenocysteine: no end bleed into intron: 0# strange splices: 0
Click here for a detailed description of the fields of the table above.

-  Methods, Credits, and Use Restrictions
  Click here for details on how this gene model was made and data restrictions if any.